Related Experiment Video
Updated: Jul 29, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Problems and pitfalls in cardiac drug therapy.
1Department of Pharmacy Services, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Medical errors cause up to 98,000 deaths annually, with medication errors contributing significantly. Educating healthcare providers on complex drug interactions is crucial for patient safety and optimal treatment outcomes.
Area of Science:
- Medical Safety
- Pharmacology
- Health Informatics
Background:
- Medical errors contribute to a significant number of patient deaths annually.
- Medication errors alone are responsible for thousands of deaths each year.
- Increasingly complex medications and accelerated approval rates necessitate enhanced safety measures.
Purpose of the Study:
- To highlight the critical role of healthcare provider awareness in mitigating medical errors.
- To emphasize the importance of patient and provider education for managing complex medications.
- To underscore the necessity of staying informed about potential drug interactions.
Main Methods:
- Review of statistics on medical error-related mortality.
- Analysis of medication complexity, approval rates, and therapeutic windows.
- Identification of educational needs for healthcare providers regarding drug interactions.
Main Results:
- Medical errors may cause 44,000 to 98,000 deaths annually.
- Medication errors account for approximately 7,000 deaths per year.
- Electronic resources can assist providers in monitoring drug-drug, drug-food, and drug-supplement interactions.
Conclusions:
- Increased provider awareness of potential errors is vital for improving medical care safety.
- Comprehensive patient and provider education is essential for optimal therapeutic outcomes with complex medications.
- Utilizing electronic resources is a key strategy for healthcare providers to manage drug interactions effectively.
More Related Videos
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Drug Toxicity: Risk factors
Drug toxicity: Drug–Drug Interaction

